c-MYC mRNA tail tale about glutamine control of transcription
- PMID: 28507224
- PMCID: PMC5494466
- DOI: 10.15252/embj.201796999
c-MYC mRNA tail tale about glutamine control of transcription
Abstract
Dejure et al (2017) demonstrates an intriguing link between glutamine, c‐
Figures
Comment on
-
The MYC mRNA 3'-UTR couples RNA polymerase II function to glutamine and ribonucleotide levels.EMBO J. 2017 Jul 3;36(13):1854-1868. doi: 10.15252/embj.201796662. Epub 2017 Apr 13. EMBO J. 2017. PMID: 28408437 Free PMC article.
References
-
- Dang CV (2017) A time for MYC: metabolism and therapy. Cold Spring Harb Symp Quant Biol 81: 79–83 - PubMed
-
- Davidson SM, Papagiannakopoulos T, Olenchock BA, Heyman JE, Keibler MA, Luengo A, Bauer MR, Jha AK, O'Brien JP, Pierce KA, Gui DY, Sullivan LB, Wasylenko TM, Subbaraj L, Chin CR, Stephanopolous G, Mott BT, Jacks T, Clish CB, Vander Heiden MG (2016) Environment impacts the metabolic dependencies of ras‐driven non‐small cell lung cancer. Cell Metab 23: 517–528 - PMC - PubMed
-
- Gross MI, Demo SD, Dennison JB, Chen L, Chernov‐Rogan T, Goyal B, Janes JR, Laidig GJ, Lewis ER, Li J, Mackinnon AL, Parlati F, Rodriguez ML, Shwonek PJ, Sjogren EB, Stanton TF, Wang T, Yang J, Zhao F, Bennett MK (2014) Antitumor activity of the glutaminase inhibitor CB‐839 in triple‐negative breast cancer. Mol Cancer Ther 13: 890–901 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
